Adaptive by Design

Biologically Informed Engineering

May 21, 2026
10:00 AM - 11:00 AM EDT
Adaptive by Design
Webinar

Location

Zoom Webinar


Webinar Recordings:

Recordings will be available exclusively to ILP members. To learn more about becoming a member, click here.


Overview

Biology offers a powerful blueprint for rethinking how we discover and build engineered systems. Adaptive by Design: Biologically Informed Engineering examines how ideas rooted in living systems, such as adaptability, efficiency, and responsive behavior, are driving new approaches to engineering across disciplines.

This Leading Edge webinar will explore how AI is accelerating hypothesis generation by identifying patterns across biology, materials science, and engineering, and how advances in sensing, imaging, and instrumentation are translating these insights into systems for testing and deployment. Together, these approaches form a continuous pipeline from idea generation to engineered application.

Through a cross‑disciplinary lens, the session will highlight how biologically informed design bridges digital and physical domains. Discussion will include perspectives on AI‑driven discovery workflows, such as the work at Unreasonable Labs, that accelerate innovation, complement experimental validation, and expand scientific and technological frontiers, as well as approaches that connect modeling, simulation, and experimentation to transform theoretical concepts into practical devices capable of interacting with real environments.


Registration Fee: 
   ILP Member: Complimentary
   General Public: $250  now $100 (60% off)
   Current MIT Faculty/Staff/Student: Complimentary

  • Overview

    Biology offers a powerful blueprint for rethinking how we discover and build engineered systems. Adaptive by Design: Biologically Informed Engineering examines how ideas rooted in living systems, such as adaptability, efficiency, and responsive behavior, are driving new approaches to engineering across disciplines.

    This Leading Edge webinar will explore how AI is accelerating hypothesis generation by identifying patterns across biology, materials science, and engineering, and how advances in sensing, imaging, and instrumentation are translating these insights into systems for testing and deployment. Together, these approaches form a continuous pipeline from idea generation to engineered application.

    Through a cross‑disciplinary lens, the session will highlight how biologically informed design bridges digital and physical domains. Discussion will include perspectives on AI‑driven discovery workflows, such as the work at Unreasonable Labs, that accelerate innovation, complement experimental validation, and expand scientific and technological frontiers, as well as approaches that connect modeling, simulation, and experimentation to transform theoretical concepts into practical devices capable of interacting with real environments.


    Registration Fee: 
       ILP Member: Complimentary
       General Public: $250  now $100 (60% off)
       Current MIT Faculty/Staff/Student: Complimentary

Register

Agenda

10:00AM

Welcome and Introduction

Program Director, MIT Corporate Relations

Natalie Kim headshot
Natalie Kim

Program Director, MIT Corporate Relations

Dr. Najung “Natalie” Kim is a Program Director at the MIT Industrial Liaison Program. She brings to the Office of Corporate Relations (OCR) expertise in strategic collaboration in life sciences and biotech industries, including cell and gene therapy and AI/ML analytics. Kim comes to OCR from Adjuvant Partners where she has been serving as Senior Consultant, Strategic Partnering, working to connect industry, startups, and academic leaders in the cell and gene therapy sector. Before Adjuvant, Natalie worked at Ajinomoto, where she was Manager of the Research & Innovation Center, facilitating collaborations on preclinical and clinical development of biologics, diagnostics, and cell therapy ancillary products in Asia, Europe, and North America. Prior to Ajinomoto, Kim was a business development manager at Medipost, where she led strategic partnerships in mesenchymal stem cell therapeutics in orthopedic and neurodegenerative applications. Kim also went through her postdoctoral training at the Wake Forest Institute for Regenerative Medicine as a Department of Defense Research Fellow working on translational gene therapy in tissue engineering programs.

Kim earned her B.S. Bioscience and Food Engineering at Handong Global University, her M.S. Medicine at Seoul National University in South Korea, and her Ph.D. Biomedical Engineering at the University of Iowa.

10:03AM

Principal Research Scientist, Department of Mechanical Engineering
Associate Director, MIT.nano
Director of Technical Operations, Center for Clinical and Translational Research

Brian W Anthony

Principal Research Scientist, Department of Mechanical Engineering
Associate Director, MIT.nano
Director of Technical Operations, Center for Clinical and Translational Research

Dr. Brian Anthony is a leading expert in the design of intelligent, or smart, instruments and methodologies for monitoring, measuring, and controlling complex physical systems. His interdisciplinary work spans mechanical, electrical, and optical engineering, seamlessly integrated with computer science and optimization, to deliver innovative solutions across manufacturing, healthcare, and other industries.

At the core of Dr. Anthony’s research is computational instrumentation—the development of advanced tools and techniques to observe and manage intricate systems, particularly in manufacturing and medical diagnostics. His contributions include pioneering measurement and imaging technologies that enhance precision and performance in both industrial and clinical settings.

With over 30 years of experience, Dr. Anthony combines deep academic insight with practical industry expertise in technology innovation, product development, and entrepreneurship. He has successfully guided market-driven solutions from concept to commercialization, especially at the intersection of information technology and advanced manufacturing. His achievements include receiving an Emmy Award from the Academy of Television Arts and Sciences for technical innovation in broadcast engineering.

In the classroom, Dr. Anthony is dedicated to teaching the modeling and analysis of large-scale systems to support decision-making in domains such as manufacturing, medicine, and entertainment. He also leads efforts in developing optimization algorithms and software tools for system design and evaluation.

Dr. Anthony’s dual roles in academia and industry position him as a bridge between cutting-edge research and real-world application, driving impactful technologies that shape the future of engineering and innovation.

10:30AM

Jerry McAfee Professor, MIT Department of Civil and Environmental Engineering 
Professor of Engineering, MIT Department of Mechanical Engineering
Co-Founder & CTO, Unreasonable Labs

Markus J. Buehler

Jerry McAfee Professor, MIT Department of Civil and Environmental Engineering 
Professor of Engineering, MIT Department of Mechanical Engineering
Co-Founder & CTO, Unreasonable Labs

Dr. Markus J. Buehler, Jerry McAfee Professor of Engineering at MIT, and Co-Founder and CTO of Unreasonable Labs, is a leading researcher in computational modeling across domains, from materials to biology to physics. Markus' expertise bridges AI to multi scale materials modeling. He recently co-developed a method that uses artificial intelligence to generate new protein designs with specific strengths, mimicking natural materials like silk. This approach, which uses computer simulations for testing, allows the creation of proteins with desired mechanical properties, such as strength and flexibility, beyond what is naturally available. Markus earned a Ph.D. at the Max Planck Institute for Metals Research at the University of Stuttgart and held post-doctoral appointments at both Caltech and MIT. Buehler has received many awards, including the Feynman Prize, the Drucker Medal, and the Washington Award. He is a member of the National Academy of Engineering. 

10:58AM

Closing

Program Director, MIT Corporate Relations

Natalie Kim headshot
Natalie Kim

Program Director, MIT Corporate Relations

Dr. Najung “Natalie” Kim is a Program Director at the MIT Industrial Liaison Program. She brings to the Office of Corporate Relations (OCR) expertise in strategic collaboration in life sciences and biotech industries, including cell and gene therapy and AI/ML analytics. Kim comes to OCR from Adjuvant Partners where she has been serving as Senior Consultant, Strategic Partnering, working to connect industry, startups, and academic leaders in the cell and gene therapy sector. Before Adjuvant, Natalie worked at Ajinomoto, where she was Manager of the Research & Innovation Center, facilitating collaborations on preclinical and clinical development of biologics, diagnostics, and cell therapy ancillary products in Asia, Europe, and North America. Prior to Ajinomoto, Kim was a business development manager at Medipost, where she led strategic partnerships in mesenchymal stem cell therapeutics in orthopedic and neurodegenerative applications. Kim also went through her postdoctoral training at the Wake Forest Institute for Regenerative Medicine as a Department of Defense Research Fellow working on translational gene therapy in tissue engineering programs.

Kim earned her B.S. Bioscience and Food Engineering at Handong Global University, her M.S. Medicine at Seoul National University in South Korea, and her Ph.D. Biomedical Engineering at the University of Iowa.

  • Agenda
    10:00AM

    Welcome and Introduction

    Program Director, MIT Corporate Relations

    Natalie Kim headshot
    Natalie Kim

    Program Director, MIT Corporate Relations

    Dr. Najung “Natalie” Kim is a Program Director at the MIT Industrial Liaison Program. She brings to the Office of Corporate Relations (OCR) expertise in strategic collaboration in life sciences and biotech industries, including cell and gene therapy and AI/ML analytics. Kim comes to OCR from Adjuvant Partners where she has been serving as Senior Consultant, Strategic Partnering, working to connect industry, startups, and academic leaders in the cell and gene therapy sector. Before Adjuvant, Natalie worked at Ajinomoto, where she was Manager of the Research & Innovation Center, facilitating collaborations on preclinical and clinical development of biologics, diagnostics, and cell therapy ancillary products in Asia, Europe, and North America. Prior to Ajinomoto, Kim was a business development manager at Medipost, where she led strategic partnerships in mesenchymal stem cell therapeutics in orthopedic and neurodegenerative applications. Kim also went through her postdoctoral training at the Wake Forest Institute for Regenerative Medicine as a Department of Defense Research Fellow working on translational gene therapy in tissue engineering programs.

    Kim earned her B.S. Bioscience and Food Engineering at Handong Global University, her M.S. Medicine at Seoul National University in South Korea, and her Ph.D. Biomedical Engineering at the University of Iowa.

    10:03AM

    Principal Research Scientist, Department of Mechanical Engineering
    Associate Director, MIT.nano
    Director of Technical Operations, Center for Clinical and Translational Research

    Brian W Anthony

    Principal Research Scientist, Department of Mechanical Engineering
    Associate Director, MIT.nano
    Director of Technical Operations, Center for Clinical and Translational Research

    Dr. Brian Anthony is a leading expert in the design of intelligent, or smart, instruments and methodologies for monitoring, measuring, and controlling complex physical systems. His interdisciplinary work spans mechanical, electrical, and optical engineering, seamlessly integrated with computer science and optimization, to deliver innovative solutions across manufacturing, healthcare, and other industries.

    At the core of Dr. Anthony’s research is computational instrumentation—the development of advanced tools and techniques to observe and manage intricate systems, particularly in manufacturing and medical diagnostics. His contributions include pioneering measurement and imaging technologies that enhance precision and performance in both industrial and clinical settings.

    With over 30 years of experience, Dr. Anthony combines deep academic insight with practical industry expertise in technology innovation, product development, and entrepreneurship. He has successfully guided market-driven solutions from concept to commercialization, especially at the intersection of information technology and advanced manufacturing. His achievements include receiving an Emmy Award from the Academy of Television Arts and Sciences for technical innovation in broadcast engineering.

    In the classroom, Dr. Anthony is dedicated to teaching the modeling and analysis of large-scale systems to support decision-making in domains such as manufacturing, medicine, and entertainment. He also leads efforts in developing optimization algorithms and software tools for system design and evaluation.

    Dr. Anthony’s dual roles in academia and industry position him as a bridge between cutting-edge research and real-world application, driving impactful technologies that shape the future of engineering and innovation.

    10:30AM

    Jerry McAfee Professor, MIT Department of Civil and Environmental Engineering 
    Professor of Engineering, MIT Department of Mechanical Engineering
    Co-Founder & CTO, Unreasonable Labs

    Markus J. Buehler

    Jerry McAfee Professor, MIT Department of Civil and Environmental Engineering 
    Professor of Engineering, MIT Department of Mechanical Engineering
    Co-Founder & CTO, Unreasonable Labs

    Dr. Markus J. Buehler, Jerry McAfee Professor of Engineering at MIT, and Co-Founder and CTO of Unreasonable Labs, is a leading researcher in computational modeling across domains, from materials to biology to physics. Markus' expertise bridges AI to multi scale materials modeling. He recently co-developed a method that uses artificial intelligence to generate new protein designs with specific strengths, mimicking natural materials like silk. This approach, which uses computer simulations for testing, allows the creation of proteins with desired mechanical properties, such as strength and flexibility, beyond what is naturally available. Markus earned a Ph.D. at the Max Planck Institute for Metals Research at the University of Stuttgart and held post-doctoral appointments at both Caltech and MIT. Buehler has received many awards, including the Feynman Prize, the Drucker Medal, and the Washington Award. He is a member of the National Academy of Engineering. 

    10:58AM

    Closing

    Program Director, MIT Corporate Relations

    Natalie Kim headshot
    Natalie Kim

    Program Director, MIT Corporate Relations

    Dr. Najung “Natalie” Kim is a Program Director at the MIT Industrial Liaison Program. She brings to the Office of Corporate Relations (OCR) expertise in strategic collaboration in life sciences and biotech industries, including cell and gene therapy and AI/ML analytics. Kim comes to OCR from Adjuvant Partners where she has been serving as Senior Consultant, Strategic Partnering, working to connect industry, startups, and academic leaders in the cell and gene therapy sector. Before Adjuvant, Natalie worked at Ajinomoto, where she was Manager of the Research & Innovation Center, facilitating collaborations on preclinical and clinical development of biologics, diagnostics, and cell therapy ancillary products in Asia, Europe, and North America. Prior to Ajinomoto, Kim was a business development manager at Medipost, where she led strategic partnerships in mesenchymal stem cell therapeutics in orthopedic and neurodegenerative applications. Kim also went through her postdoctoral training at the Wake Forest Institute for Regenerative Medicine as a Department of Defense Research Fellow working on translational gene therapy in tissue engineering programs.

    Kim earned her B.S. Bioscience and Food Engineering at Handong Global University, her M.S. Medicine at Seoul National University in South Korea, and her Ph.D. Biomedical Engineering at the University of Iowa.